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Amphetamines are highly addictive drugs that have pronounced effects on emotional and cognitive behavior in humans. These effects are
mediated through their potent dopaminergic agonistic properties. Dopamine has also been implicated in the modulation of responses of
the ‘reward circuit’ in animal and human studies. In this study we use functional magnetic resonance imaging (fMRI) to identify the brain
circuitry involved in the psychostimulant effect of methamphetamine in psychostimulant-naı̈ve human subjects. Seven healthy volunteers
were scanned in a 3T MR imaging system. They received single-blind intravenous infusions of methamphetamine (0.15 mg/kg), and rated
their experience of ‘mind-racing’ on a button press throughout the experiment. Data were analyzed with statistical parametric mapping
methods. Amphetamine administration activated the medial orbitofrontal cortex, the rostral part of the anterior cingulate cortex, and the
ventral striatum. Ratings of ‘mind-racing’ after methamphetamine infusion correlated with activations in the rostral part of the anterior
cingulate cortex and in the ventral striatum. In addition, activations in the medial orbitofrontal cortex were independent of motor and
related responses involved in making the ratings. These findings indicate that the first administration of a psychostimulant to human
subjects activates classical reward circuitry. Our data also support recent hypotheses suggesting a central role for the orbitofrontal cortex
in drug reinforcement and the development of addiction.
Neuropsychopharmacology advance online publication, 12 May 2004; doi:10.1038/sj.npp.1300481

















































Amphetamines are widely abused for their stimulant and
euphoriant properties (Murray, 1998). In particular, the
methylated derivative, methamphetamine, is a highly
addictive drug known for its potent reinforcing effects, as
observed in monkeys (Woolverton et al, 1984) and humans
(Volkow et al, 2001). Animal and human studies suggest
that these effects are mediated through activation of the
mesolimbic dopamine system, which innervates limbic and
cortical areas including the ventral striatum, orbitofrontal
cortex, and anterior cingulate cortex to form a ‘reward
circuit’ (Rolls, 1999; Goldstein and Volkow, 2002).
Within this reward circuitry, a critical role would appear
to be played by the orbitofrontal cortex. This region has
been shown to be centrally involved in the representation of
primary and secondary reinforcers in the primate brain,
including humans (Rolls, 1999, 2000). It has been shown
that macaques will work to self-administer D-amphetamine
into the orbitofrontal cortex (Phillips and Rolls, 1981). In
humans, abnormal metabolic activity and low levels of D2
dopamine receptor availability have been observed in the
orbitofrontal cortex of methamphetamine abusers (Volkow
et al, 2001), which confirms analogous findings in cocaine,
alcohol, and heroin abusers and leads to the hypothesis that
disruption of (orbito)frontal cortical circuits may lead to
compulsive drug intake (Volkow and Fowler, 2000; Volkow
et al, 2001; Goldstein and Volkow, 2002).
Although the role of reward-related circuitries in addic-
tion has been previously explored by applying functional
imaging to study the responses to drug administration in
the brains of people with substance abuse disorders (eg
Breiter et al, 1997), relatively little is known about the
responses in these brain regions to drug administration
during the initial stages of addiction or in the case of drug-
naı̈ve subjects.
In this study we use functional magnetic resonance
imaging (fMRI), a noninvasive functional brain mapping
technique with high spatial and temporal resolution, to
demonstrate that intravenous methamphetamine adminis-
tered to drug-naı̈ve subjects produces limbic and cortical
activations consistent with postulated reward circuitry, in
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particular in the orbitofrontal cortex. These activations
correlate with behavioral ratings reflecting the subjective
effects produced by methamphetamine administration.
MATERIALS AND METHODS
Subjects
The participants of the study were seven right-handed
volunteers (four women, three men, mean age 29.1 years),
who were psychostimulant-naı̈ve. Subjects were medically
fit and had no history of head injury and no current or
past Axis I DSM-IV disorder, including substance abuse/
dependence on the basis of the Structured Clinical Interview
for DSM-IV, clinician version (First et al, 1996). They had
all been free of psychotropic medication for 1 year prior to
the scan. Subjects were asked whether they had ever taken
any psychotropic medication (ie medication to alleviate
depression, anxiety, or other psychological disturbances).
This was the case only for one subject who had taken
psychotropic medication several years previous to the
experiment. All subjects gave written informed consent
for the study, which was approved by the local ethics
committee.
Experimental Design
The study was a single-blind within-subjects design.
Subjects received intravenous saline for a random period
of 10–15 min, followed by i.v. methamphetamine (0.15 mg/
kg) delivered over a 1 min period. The choice of this specific
dose was based on pilot data obtained from drug-naı̈ve
volunteers where it was established as the smallest i.v. dose
that reliably separated the effects of methamphetamine
from placebo on subjective ratings. In addition, it is in line
with previous studies (eg Kleinschmidt et al, 1999 who used
a fixed dose of 15 mg i.v. methamphetamine). The infusion
was administered via an infusion pump that was located in a
separate room. This enabled us to switch from saline to the
active drug without the subjects being aware of this. They
had been told that there was a 50% probability that they
would receive the active drug. After the methamphetamine
infusion, saline was restarted for a further 25–30 min.
Functional images were obtained throughout the whole
experiment, which lasted 41 min in total. Subjects rated
themselves at 1-min intervals on a right-handed button
press for the subjective experience of ‘mind racing’. Ratings
ranged from 0 (no mind racing) to 4 (high). Increases in
this rating have been shown to correlate with the overall
psychostimulant effect of methamphetamine and to be
attenuated by dopamine depletion (McTavish et al, 1999;
see also ‘Discussion’). ‘Mind racing’ was introduced and
fully explained to each subject as follows: ‘Mind racing is a
condition you would not normally experience in day to day
life. It is a state where your thoughts run far too quickly as if
they were racing. One thought is replaced by another very
quickly and it is difficult to hold on to your thoughts. You
might have experienced a similar condition when you were
very anxious or excited.’ Following the scanning session,
each participant was asked to describe their subjective
experience. All subjects reported that they were well able to
identify the subjective experience of mind racing as it
occurred.
An arbitrary visual stimulus, the letter ‘L’, was displayed
on the screen during the experiment (including both the
amphetamine and saline periods). Once a minute, the
ratings were cued by another arbitrary visual stimulus, the
letter ‘V’, which was displayed on a screen for 0.5 s. This
stimulus then changed back to ‘L’, which was shown for the
remaining time.
Image Acquisition
Functional magnetic resonance (fMRI) images were ac-
quired using a 3 Tesla Varian Inova MR imaging system.
Each volume comprised 40 T2*-weighted contiguous axial
slices (slice thickness¼ 6 mm, slice gap¼ 0 mm), acquired
transversally using a single shot echo planar (EPI) pulse
sequence (TR¼ 5 s). The in-plane field of view was
26.5 26.5 cm2. The matrix dimensions were 64 64 with
a voxel resolution of 4 4 mm2 in-plane (a 8 8 mm2
Gaussian filter was used for spatial smoothing). A reference
whole-brain EPI scan was acquired for each subject. We
used a set of optimizing techniques to select the imaging
parameters in order to minimize susceptibility and distor-
tion artifacts in the orbitofrontal cortex as described in
detail by Wilson et al (2000). The relevant factors include
minimizing voxel size in the plane of the imaging, as high a
gradient switching frequency as possible (960 Hz), a short
echo time of 25 ms, and local shimming for the inferior
frontal area.
Data Analysis
Imaging data were analyzed using SPM99 (Wellcome
Department of Imaging Neuroscience, Institute of Neurol-
ogy, London). Preprocessing of the data used SPM99
realignment and reslicing with sinc interpolation. FLIRT
(FMRIB Centre, Oxford) was used to carry out intermodal
registration and spatial normalization to the Montreal
Neurological Institute (MNI)-brain (Collins et al, 1994).
MNI coordinates were transformed into the Talairach
coordinate system (Talairach and Tournoux, 1988) for
description of the results. Spatial smoothing was applied
with an 8 mm full-width at half-maximum isotropic
Gaussian kernel. The time series at each voxel were high-
pass (cutoff period 650 s) and low-pass filtered (by
convolving the time series with a hemodynamic response
kernel; Friston et al, 1994).
A general linear model was then applied to the time
course of activation of each voxel. In order to investigate the
brain activations related to amphetamine, three different
models were constructed for each individual data set. An
on–off model was designed to test for the main effects of
amphetamine on the BOLD response. Based on the
inspections of the changes in subjective ratings (see
Figure 1), the ‘on’ period was modeled as an epoch having
its onset 5 min after the start of the amphetamine injection
and lasting for 10 min. The ‘off’ epoch was the period during
the initial saline infusion.
For the correlation analysis, the rating onsets were
modeled as single impulse response functions (ie an
event-related design) and then convolved with the canonical
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hemodynamic response function (HRF, Friston et al, 1994).
The derivative of the HRF was included in the basis
functions set. For each individual data set, the time series
were linearly modulated by the behavioral ratings given by
the subjects (‘parametric modulation’).
Linear contrasts of parameter estimates were then defined
to test the specific effects of each condition within each
individual data set. Voxel values for each contrast resulted
in a statistical parametric map of the corresponding t
statistic, which was then transformed into the unit normal
distribution (SPM Z). The statistical parametric maps from
each individual data set were then entered into second-level,
random effects analyses accounting for both scan-to-scan
and subject-to-subject variability. The group effects of
interest were assessed through applying one-sample t-tests
to the first-level Z-maps.
Further, we were interested in studying the effects of
methamphetamine in reward-related areas when no motor-
related responses were being given, to exclude the
possibility that the activations observed resulted from an
enhancement of central correlates of motor and related
activity involved in making the ratings, including the button
press, by amphetamine. The nonmotor related events of the
task were (linearly) modeled in each individual data set by
selecting a box-car basis function with onsets defined with a
delay of 30 s with respect to the button press event (the
ratings were given at every minute) and with a duration of
30 s. The cutoff period for the high-pass temporal filter was
set to 1200 s, and no low-pass temporal filtering or global
scaling was used. The value for the high-pass temporal
filtering was designed in order to allow long-lasting, state-
related, effects of the drug to be revealed in the statistical
analysis. This value also ensured that only within-subjects
changes were modeled by the SPM analysis. A linear
contrast was defined to test the comparison amphetamine
epoch vs saline epoch in the group analysis. These two time
periods were defined using the timing frames described
above for the ‘on’ and ‘off’ periods. As for the other two
models, the statistical parametric maps from each indivi-
dual data set were entered into a second-level, random
effects analysis and the group effects of interest were
assessed through applying one-sample t-tests to the first-
level Z-maps.
The present study reports p-values based on a group
analysis for a priori regions of interest given the strong
hypotheses generated by previous independent studies
(Breiter and Rosen, 1999; Vollenweider et al, 1998; Gold-
stein and Volkow, 2002; Martinez et al, 2003; Volkow et al,
2001, 2002). The p-values were corrected for the number of
comparisons made within each region using the small
volume correction (SVC) procedure (Worsley et al, 1996)
consisting of defining a 10 mm sphere centered at the peak
voxel of activation clusters. A priori regions of interest
included the medial orbitofrontal cortex (Goldstein and
Volkow, 2002; Volkow et al, 2001), the anterior cingulate
cortex (Vollenweider et al, 1998; Volkow et al, 2002), and
the (ventral) striatum (Breiter and Rosen, 1999; Martinez
et al, 2003). Finally, checks were performed using the
estimated motion as a covariate of no interest to rule out the




All subjects tolerated the drug challenge without difficulty.
The time course of subjective ratings, averaged across
subjects (mean7SEM), is shown in Figure 1. The average
onset of the amphetamine infusion (across subjects) is
shown by the ‘X’ symbol. All subjects experienced an
increase in ‘mind racing’ within 2–3 min after the infusion,
peaking at 10–15 min postinfusion. By the end of the
experiment ratings were closer to baseline. Subjective
reports taken from participants immediately after the
experiment indicated that they experienced the subjective
drug effects as positive and rewarding.
Functional MRI Results
Results for all activations are shown in Table 1.
On–off model. The comparison (Amphetamine–Saline) (see
‘Materials and methods’) produced significant activations in
the medial part of the orbitofrontal cortex (Talairach
coordinates [16 38 8], Z¼ 3.26, po0.01 SVC) and in the
rostral part of the anterior cingulate cortex ([2 24 5],
Z¼ 3.19, po0.01 SVC) where it borders ventrally the medial
part of the orbitofrontal cortex. Less robust but significant
activations were found in the right caudate nucleus where it
borders the right putamen ([16 18 9], Z¼ 2.79, po0.05
SVC). A further cluster of activation was observed in the
right caudate nucleus ([13 19 0], Z¼ 2.39, po0.005
uncorrected). A cluster of activation was also found in the
left motor cortex ([4 12 68], Z¼ 2.89, po0.005
uncorrected). The results are illustrated in Figure 2.
Correlation analysis. Correlation of the BOLD fMRI signal
with individual mind-racing ratings (see ‘Materials and
methods’) was significant in the caudate nucleus ([5 15 1],
Figure 1 Averaged (mean7SEM) behavioral (‘mind racing’) ratings given
by subjects across the experiment. The ‘X’ in the time axis shows the
average time of the amphetamine infusion.
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Z¼ 3.38, po0.005 SVC) and in the rostral part of
the anterior cingulate cortex ([0 32 1], Z¼ 3.06,
po0.005 SVC). These activations are depicted in Figure 3.
At lower thresholds a significant correlation was found
in the orbitofrontal cortex ([39 44 8], Z¼ 2.81, po0.01
uncorrected), and the rostral anterior cingulate activa-
tion just described extended into the medial orbitofrontal
cortex.
Activations independent of motor response. Activations
produced by amphetamine (as compared to saline), which
were independent of the motor responses produced during
the rating period (see ‘Materials and Methods’), were found
in the medial part of the orbitofrontal cortex ([11 38 8],
Z¼ 3.66, po0.04. SVC). This cluster of activation overlaps
with the medial orbitofrontal cluster found to be activated
in the comparison (Amphetamine–Saline) (see above). This
Table 1 Foci of Activation Clusters within Regions of Interest
Talairach coordinates of maximum activity
Brain region x y Z Cluster size (voxels) Z Score p (SVC)
Amphetamine–Saline
Medial orbitofrontal cortex 16 38 8 74 3.26 0.01
Rostral anterior cingulate 2 24 5 44 3.19 0.01
Caudate/putamen 16 18 9 16 2.79 0.05
Caudate nucleus 13 19 0 8 2.39 0.005a
Correlation analysis
Caudate nucleus 5 15 1 103 3.38 0.005
Lateral orbitofrontal cortex 39 44 8 10 2.81 0.01a
Rostral anterior cingulate extending to medial OFC 0 32 1 56 3.06 0.005
Motor independent responses
Medial orbitofrontal cortex 11 38 8 61 3.66 0.04
aUncorrected.
Figure 2 Results of the comparison Amphetamine–Saline. Activations
(shown within the white circles) were found in (a) the medial orbitofrontal
cortex, (b) ventral striatum, and (c) anterior cingulate cortex, and motor
cortex (red circle). The p-values shown are with the small volume
correction procedure (SVC, see ‘Materials and methods’).
Figure 3 Results of the SPM analysis correlating changes in BOLD signal
with subjective ratings of ‘mind-racing’ produced by methamphetamine.
Correlated activations (shown within the white circles) were found in (a)
the medial prefrontal cortex (rostral anterior cingulate cortex), (b) ventral
striatum, and (c) orbitofrontal cortex. The p-values shown are with the
small volume correction procedure (SVC, see ‘Materials and methods’).
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activation is shown in Figure 4, superimposed on a high-
resolution T1 MRI scan (and on the mean normalized EPI
averaged across the seven subjects to show the good signal
recovery in the orbital region).
Further analysis was carried out on this medial orbito-
frontal cluster shown in Figure 4. The raw (time-series)
signals from the voxels in this cluster were extracted and
averaged across all the peristimulus time periods (ie the
1 min following a button press response) during the
preinfusion (saline) and postinfusion (amphetamine) parts
of the experiment. The average signals are shown in Figure
5(a). This graph demonstrates that this region of the
orbitofrontal cortex was consistently activated by metham-
phetamine administration, whereas saline administration
did not shift the signal from baseline. This increase was not
dependent on motor responses: In Figure 5(b) we show the
signal extracted from a motor cortex cluster (continuous
with the cluster shown in Figure 2(c)), showing that in this
case the activation is locked to the motor response that
provided the ratings.
DISCUSSION
This study used fMRI to assess the responses in the human
brain to intravenous administration of methamphetamine
in amphetamine-naı̈ve, healthy subjects. First, we showed
that intravenous methamphetamine administration, when
compared to saline administration, produces activity in
reward- and affect-related areas of the human brain
including the medial orbitofrontal cortex, the rostral
anterior cingulate cortex and the (ventral) striatum. Second,
activity in these areas was shown to correlate with the
subjective ratings reflecting the effects of methamphetamine
administration. Third, we have specifically shown that the
orbitofrontal cortex is robustly activated by methampheta-
mine, in that increases in activation were observed across
the whole period following drug administration, and that
these responses were not dependent on motor-related
activity. This last finding provides evidence that the
orbitofrontal cortex activation produced by methampheta-
mine is related to the nonphasic, nonmovement-related
effects produced by amphetamine, which include effects
such as mind racing, reward, and related effects that may be
involved in the development of compulsive drug-intake and
addiction (Volkow and Fowler, 2000; Volkow et al, 2001;
Goldstein and Volkow, 2002).
Inspection of the behavioral data time courses indicates
that the subjective ratings of ‘mind-racing’ did reflect the
effects of amphetamine administration; this is in line with
previous findings (McTavish et al, 1999). The cingulate and
ventral striatum activations that correlated with these
subjective experiences (see Figure 3) are in agreement with
the PET study by Vollenweider et al (1998), where it was
shown that d-amphetamine produced a mania-like syn-
drome concomitantly with a widespread increase in
absolute cerebral metabolism, which was significant in the
anterior cingulate cortex, caudate nucleus, putamen, and
thalamus. Dopamine release in the ventral striatum is linked
to the rewarding and locomotor-stimulant effects of abused
drugs such as amphetamine in experimental animals
(Parkinson et al, 1999). In particular, conditioned reinfor-
cement tasks are potentiated by amphetamine administra-
tion (Cardinal et al, 2002), and this potentiation is known to
depend on dopamine innervation of the nucleus accumbens
(Taylor and Robbins, 1986). In humans, this region was
shown through fMRI to be activated by cocaine adminis-
Figure 4 Activations in the medial orbitofrontal cortex (for the
comparison (Amphetamine–Saline)) when no motor responses are being
made. The most significant cluster of activated voxels for this comparison is
shown. (a) The activation is shown superimposed on a high-resolution T1
MRI coronal image. (b) The activation is shown superimposed on an EPI
image obtained by averaging normalized mean EPI scans across all seven
subjects. Coronal and axial images are shown. This illustrates good signal
recovery in the orbitofrontal cortex region.
Figure 5 (a) fMRI time course of activations extracted from the
orbitofrontal cortex cluster shown in Figure 4. The graph shows robust
responses to amphetamine in this area in a way that is independent of the
time of the button press made to give the rating at time 0 in the graph. No
significant response in this region was produced during saline administration
(prior to the amphetamine infusion). (b) Time course of activation
extracted from a cluster in the motor cortex area illustrated in Figure 2(c),
red circle. In this case, a robust brain activation follows the button press
event in contrast to the time course shown in (a). No significant difference
was found between the amphetamine and saline periods in this region.
Activation of reward circuitry in drug naı̈ve human subjects
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tration in cocaine abusers (Breiter et al, 1997; Breiter and
Rosen, 1999).
The results described based on the correlation analysis
are due largely to an effect of amphetamine on brain
processes that occurred at about the time the ratings were
given and the button press response was being made.
Whether these effects of amphetamine are related to the
cognitive evaluation of the current state of mind racing, or
to the movements being made to press the button, is
difficult to establish. To study brain activations that are
independent of motor activity, we therefore used a model in
which the event onsets were delayed with respect to the
ratings. This analysis revealed a significant cluster of
activation in the orbitofrontal cortex (Figure 4), which
was not dependent on motor responses (as shown by the
time course analysis illustrated in Figure 5). Activation in
this area was found to be robust across the period following
amphetamine injection, and was only revealed by the
particular design used here. The fact that motor-indepen-
dent activations were not found in other regions (such as
the ventral striatum) could be for a number of reasons. One
is that they may have been present, but were just not
statistically significant. Another is that amphetamine
increases activity in some of these regions (e.g. the ventral
striatum, as shown in Figure 2) only in relation to the
processes involved in giving the ratings such as motor
movements.
The finding of significant orbitofrontal cortex activations
independent of motor activity in drug-naı̈ve subjects is of
significance in the light of the proposed role of the
orbitofrontal cortex in drug addiction (Volkow et al,
2001). The role of the primate orbitofrontal cortex in
reward processing has been consistently established by
neuronal recording studies (Rolls et al, 1989; Rolls, 1999,
2000). Evidence that, in humans, the orbitofrontal cortex
is involved in reward processing comes from studies
making use of a variety of stimuli, such as odor (Anderson
et al, 2003; Rolls et al, 2003b), olfactory stimuli in a sensory-
specific satiety paradigm (O’Doherty et al, 2001),
face attractiveness (O’Doherty et al, 2003), sexually arousing
stimuli (Redoute et al, 2000), pleasant touch (Rolls et al,
2003a), consonant music sequences (Blood et al, 1999), food
in the mouth when hungry (Kringelbach et al, 2003) and
water in the mouth when thirsty (de Araujo et al, 2003).
Based on these comparisons, we suggest that the activation
of the orbitofrontal cortex by amphetamine reflects activa-
tion of one of the areas in the brain where amphetamine
acts to produce rewarding effects and the associated
subjective states. This is in line with the evidence that
macaques will learn to self-administer very small quantities
of amphetamine to this region (Phillips and Rolls, 1981),
and that this is a region where electrical stimulation in
macaques is rewarding (Rolls, 2000). This is also in line
with the fact that the human orbitofrontal cortex region is
in an area in which there are high concentrations of D1
receptors (Hurd et al, 2001), and abnormal metabolic
activity and low availability of dopamine D2 receptors have
been found in this area in the brain of drug addicts (Volkow
et al, 2001).
In line with the above, the effects of amphetamine
administration on human affective processing have been
consistently established. In particular, a recent fMRI study
by Hariri et al (2002) has shown that dextroamphetamine
potentiated the amygdala response during the perceptual
processing of angry and fearful facial expressions. This
result is particularly interesting given the strong connectiv-
ity of the amygdala with the orbitofrontal cortex in primates
(Rolls, 2000; Cavada et al, 2000). Cognitive processing,
which depends on the prefrontal circuitry, can also be
modulated by amphetamine administration. Of special
interest is the fact that working memory performance is
enhanced by amphetamine administration in subjects with
relatively low working-memory capacity at baseline,
whereas the reverse was found in high-capacity subjects
(Mattay et al, 2000; Mattay et al, 2003).
Some limitations of the current study are worth
mentioning. First, we used ‘mind racing’ for self-rating
rather than other subjective drug effects that emphasize the
emotional experience, such as ‘rush’, ‘buzz’ or ‘euphoria’. It
could be argued, therefore, that because of the behavioral
measure used no inferences about the experience of reward
can be made. However, ‘mind-racing’ has previously been
shown to correlate with the overall psychostimulant effect of
the drug in drug-naı̈ve subjects (McTavish et al, 1999;
McTavish et al, 2001). Specifically, McTavish et al (2001)
showed this measure to be highly correlated with the
rewarding experience of ‘buzz’. These authors administered
methamphetamine intravenously in a tyrosine depletion
study in which subjective measurements of ‘mind-racing’,
‘buzz’, ‘feeling good’, ‘alert’, ‘hunger’, and ‘depression’ were
collected. Only the measurements of ‘buzz’ and ‘mind-
racing’ were significantly attenuated by this dopamine-
depleting treatment, of which ‘mind-racing’ was most
significant. This suggests that ‘mind-racing’ may be the
subjective experience most related to dopamine neuro-
transmission.
Furthermore, the attenuation of cognitive activation-
related increases in frontocortical regions under ampheta-
mine (Gouzoulis-Mayfrank et al, 1999) goes against the
conclusion that the activations we found represent corre-
lates of cognitive phenomena only.
Second, the effects of methamphetamine administration
on brain activity reported in this study are unlikely to be
explained by peripheral changes caused by the drug such as
heart-rate or respiratory changes. Part of the evidence for
this is that only well-defined regions in the brain were found
to be significantly activated by the drug, or to correlate with
the ‘mind racing’ ratings. In addition, hemodilution effects
related to intravenous drug administration would not
explain the sharp onset of the effect after the amphetamine
infusion, given that the experimental protocol starts with
the saline administration. Furthermore, Kahn et al (1989) in
a study with normal volunteers suggested decreases rather
than increases in cerebral blood flow (measured by 133Xe
inhalation) occur after i.v. amphetamine despite increases
in autonomic and behavioral arousal.
Finally, as subjective ratings were indicated by button
press, in some brain areas the activations described could
reflect a modulation by methamphetamine of the neural
processes associated with cued finger movement. Uftring
et al (2001) showed a significant increase in the number of
activated voxels in the primary sensorimotor cortex during
a simple motor task. However, on the basis of our analysis
of the time course of activations in the orbitofrontal cortex,
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we could establish that the neuronal activations found in
this area were not dependent on motor activity.
In conclusion, our findings support proposals implicating
an important role of the orbitofrontal cortex in reward,
particularly with respect to its putative role in drug
addiction. As our subjects had no previous exposure to
psychostimulants, our results are uncomplicated by phe-
nomena such as craving and cued recall which would be
present in drug-dependent individuals.
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